P/E ratio for OPKO Health (OPK)

P/E ratio history for OPKO Health from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	10.8	-279.70%	🇺🇸 USA
Abbott Laboratories ABT	38.7	-745.03%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	20.9	-449.09%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	-8.38	39.58%	🇮🇱 Israel
Alnylam Pharmaceuticals ALNY	-62.8	945.86%	🇺🇸 USA
Bristol-Myers Squibb BMY	14.7	-345.59%	🇺🇸 USA
LabCorp LH	31.7	-627.88%	🇺🇸 USA
Ardelyx ARDX	-39.3	554.17%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.